Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Int J Immunopathol Pharmacol ; 27(1): 97-102, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24674683

RESUMO

Osteopontin (OPN) is an extracellular matrix protein implicated in bone remodeling, but it presents also pro-inflammatory and pro-fibrotic properties. OPN expression also occurs upon exposure of cells to classical mediators of acute inflammation such as tumor necrosis growth factor alpha (TNF-alpha) and interleukin-1 beta (IL-1beta), as well as fibrogenic cytokines such as transforming growth factor beta (TGF-beta), although a detailed understanding of these regulatory pathways is still unknown. Plasma OPN levels in both limited and diffuse systemic sclerosis patients (lSSc and dSSc) were statistically higher compared to those of control subjects. Immunohistology demonstrated that high TGF-beta levels, alpha smooth muscle actin (alphaSMA) levels and consequently high OPN levels were found in the affected skin of sclerodermic patients (lSSc and dSSc) compared to levels found in healthy skin. In order to better understand how OPN interferes with the fibrotic process, healthy skin fibroblasts were treated for 24 and 48 hours with bleomycin and with endothelin-1 (ET-1) plus TGF-beta in order to induce the fibrogenesis. After 48 hours of stimulation, healthy treated fibroblasts showed statistically increased alphaSMA levels (index of differentiation into myofibroblasts) and simultaneously statistically increased OPN levels compared to healthy untreated ones. This study demonstrates that OPN levels increase simultaneously with the increasing of alphaSMA levels, therefore it is reasonable to hypothesize that OPN interferes in the pathogenesis of Systemic Sclerosis in the early stage of fibroblast differentiation process.


Assuntos
Actinas/metabolismo , Diferenciação Celular , Fibroblastos/metabolismo , Osteopontina/metabolismo , Escleroderma Sistêmico/etiologia , Bleomicina/farmacologia , Western Blotting , Estudos de Casos e Controles , Células Cultivadas , Endotelina-1/farmacologia , Ensaio de Imunoadsorção Enzimática , Feminino , Fibroblastos/efeitos dos fármacos , Fibroblastos/patologia , Humanos , Imuno-Histoquímica , Pessoa de Meia-Idade , Osteopontina/sangue , Escleroderma Sistêmico/sangue , Escleroderma Sistêmico/metabolismo , Escleroderma Sistêmico/patologia , Fator de Crescimento Transformador beta/farmacologia
2.
Scand J Rheumatol ; 41(5): 391-5, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23043266

RESUMO

OBJECTIVES: Relaxin (RLX) is involved in extracellular matrix and collagen remodelling. The therapeutic role of the circulating isoform RLX-2 as an anti-fibrotic factor in systemic sclerosis (SSc) has been investigated. Several RLX family peptide receptors (RXFPs) are recognized in humans: RLX-2 is a ligand for RXFP1/LGR7 and RXFP2/LGR8. The aim of this study was to define the pattern of expression of LGR7 in different types of human skin cells and to compare normal skin with lesional and unaffected skin from patients with limited SSc (lSSc). METHOD: We analysed RXFP1 immunolocalization on skin biopsies and cultured fibroblasts from lSSc patients and control subjects. Western blot analysis was carried out on fibroblast lysates. RESULTS: RXFP1 showed cytoplasmic localization on skin cells from control subjects and non-lesional skin from lSSc patients: keratinocytes, gland epithelial cells, endothelium, smooth muscle cells, and fibroblasts. Immunogold electron microscopy confirmed a diffuse epithelial cytoplasmic localization of RXFP1. A substantially lower RXFP1 expression was observed in scleroderma skin, with a lack of staining in most cells. Occasional weak reactivity was observed in cultured scleroderma fibroblasts, while control fibroblasts showed a diffuse cytoplasmic immunoreactivity of RXFP1, confirmed by Western blot analysis. CONCLUSIONS: The decreased cellular expression of RLX-2 receptor RXFP1 in scleroderma skin might represent a pro-fibrotic factor and contribute to the substantial inefficacy of RLX treatment in SSc, as reported in the literature. The pathophysiology of the decrease in RXFP1 may be linked to high RLX-2 serum levels previously detected in SSc, but it has yet to be elucidated.


Assuntos
Fibroblastos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Receptores de Peptídeos/metabolismo , Escleroderma Sistêmico/metabolismo , Pele/metabolismo , Idoso , Células Cultivadas , Feminino , Fibroblastos/patologia , Fibrose/metabolismo , Fibrose/patologia , Humanos , Pessoa de Meia-Idade , Escleroderma Sistêmico/patologia , Pele/patologia
3.
Carcinogenesis ; 30(6): 960-7, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19386580

RESUMO

Calpains are cysteine proteases comprising members ubiquitously expressed in human tissues and other tissue-specific isoforms. Alterations of calpain 3 (p94), the muscle-specific isoform that contains three peculiar sequences (NS, IS1 and IS2), are strictly associated to the limb-girdle muscular dystrophy type 2A, in which a myonuclear apoptosis has been documented. Our recent demonstration of a proapoptotic role of ubiquitous calpains in drug-induced apoptosis of melanoma cells prompted us to investigate the expression of calpain 3 in human melanoma cell lines undergoing apoptosis and in melanocytic lesions. In melanoma cell lines, we have identified two novel splicing variants of calpain 3 (hMp78 and hMp84): they have an atypical initiation exon and a putative nuclear localization signal, the shorter one lacks IS1 inset and both proteins are extremely unstable. Virtually, both isoforms (prevalently as cleavage forms) are localized in cytoplasm and in nucleoli. In cisplatin-treated preapoptotic cells, an increase of both transcription and autoproteolytic cleavage of the novel variants is observed; the latter event is prevented by the inhibitor of ubiquitous calpains, calpeptin, which is also able to protect from apoptosis. Interestingly, among melanocytic lesions, the expression of these novel variants is significantly downregulated, compared with benign nevi, in the most aggressive ones, i.e. in vertical growth phase melanoma and, even more, in metastatic melanoma cells, characterized by invasiveness properties and usually highly resistant to apoptosis. On the whole, our observations suggest that calpain 3 variants can play a proapoptotic role in melanoma cells and its downregulation, as observed in highly aggressive lesions, could contribute to melanoma progression.


Assuntos
Antineoplásicos/farmacologia , Calpaína/metabolismo , Cisplatino/farmacologia , Melanoma/metabolismo , Proteínas Musculares/metabolismo , Nevo/metabolismo , Neoplasias Cutâneas/metabolismo , Processamento Alternativo , Apoptose , Biópsia , Calpaína/antagonistas & inibidores , Linhagem Celular Tumoral , Nucléolo Celular/metabolismo , Citoplasma/metabolismo , Dipeptídeos/farmacologia , Síndrome do Nevo Displásico/metabolismo , Regulação Neoplásica da Expressão Gênica , Humanos , Melanoma/patologia , Proteínas Musculares/antagonistas & inibidores , Metástase Neoplásica , RNA Mensageiro/metabolismo , Neoplasias Cutâneas/patologia
5.
G Ital Med Lav Ergon ; 29(4): 898-902, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18409262

RESUMO

The Authors, after a survey of the latest experimental and epidemiological studies concerning the possible role of crystalline silica in lung carcinogenicity, examine the cases acknowledged by the INAIL in Genoa concerning subjects suffering from silicosis who, thereafter, developed a lung cancer in the period 1979 - 2004. Distribution of the degree of disability, of the length of occupational exposure to silica, of the workers' age at the time of death and of the different fields of activity have been tested; smoking habits and histological classification of the neoplasms have also been assessed, when available. Our data seem to agree with the point of view of the Authors who so far have expressed perplexities about the role played by silica in lung carcinogenesis, especially if associated with the exposure to powerful carcinogenic agents such as cigarette smoke. At present we share the opinion of those who think that a final regulation should be delayed up to the time when it will be possible to identify the occupational source of silica with such characteristic as to make it actually carcinogenic.


Assuntos
Adenocarcinoma/epidemiologia , Carcinoma de Células Escamosas/epidemiologia , Neoplasias Pulmonares/epidemiologia , Exposição Ocupacional/efeitos adversos , Sistema de Registros , Dióxido de Silício/efeitos adversos , Silicose/complicações , Adenocarcinoma/mortalidade , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Escamosas/mortalidade , Humanos , Itália/epidemiologia , Neoplasias Pulmonares/mortalidade , Pessoa de Meia-Idade , Fatores de Risco , Silicose/epidemiologia , Fumar/efeitos adversos , Fatores de Tempo
6.
Brachytherapy ; 15(1): 1-11, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26561277

RESUMO

PURPOSE: To update brachytherapy recommendations for pretreatment evaluation, treatment, and dosimetric issues for thoracic brachytherapy for lung cancer. METHODS AND MATERIALS: Members of the American Brachytherapy Society with expertise in thoracic brachytherapy updated recommendations for thoracic brachytherapy based on literature review and clinical experience. RESULTS: The American Brachytherapy Society consensus guidelines recommend the use of endobronchial brachytherapy for disease palliation in patients with central obstructing lesions, particularly in patients who have previously received external beam radiotherapy. The use of interstitial implants after incomplete resection may improve outcomes and provide enhanced palliation. Early reports support the use of CT-guided intratumoral volume implants within clinical studies. The use of brachytherapy routinely after sublobar resection is not generally recommended, unless within the confines of a clinical trial or a registry. CONCLUSIONS: American Brachytherapy Society recommendations for thoracic brachytherapy are provided. Practitioners are encouraged to follow these guidelines and to develop further clinical trials to examine this treatment modality to increase the evidence base for its use.


Assuntos
Braquiterapia , Consenso , Neoplasias Pulmonares/radioterapia , Cuidados Paliativos , Braquiterapia/métodos , Humanos , Seleção de Pacientes , Radioterapia Adjuvante , Estados Unidos
7.
Toxicology ; 208(3): 389-98, 2005 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-15695024

RESUMO

The ability of cadmium to disrupt calcium homeostasis has been known since a long time, but the precise cellular targets of its toxic action are still debated. A great problem in the interpretation of data has been associated with the ability of cadmium to strongly bind traditional calcium probes. Aequorin, the well-characterized calcium-sensitive photoprotein, was used as intracellular calcium indicator during cadmium injury in NIH 3T3 murine fibroblasts. NIH 3T3 cells were transfected with a cDNA construct containing aequorin fused to a truncated glutamate receptor, which directs the probe to the outer surface of intracellular membranes. At first, we tested if different cadmium concentrations were able to modify the rate of light emission by aequorin showing that cadmium concentrations <15 microM were ineffective on aequorin luminescence. Hence, aequorin chimeras revealed as a useful tool in the analyses of Cd2+/Ca2+ interference. To directly investigate the role of Cd2+ in Ca2+ homeostasis, we have started to selectively measure the free Ca2+ concentration in different cell compartments. Here, we report that cadmium reduces the transient free calcium signal after stimulation of cells with bradykinin. Further studies are in progress to clarify the role of mitochondria and endoplasmic reticulum in cadmium-induced alterations of Ca2+ homeostasis in order to link signal transduction modifications with the onset of apoptosis induced by cadmium exposure.


Assuntos
Equorina/metabolismo , Cádmio/toxicidade , Cálcio/análise , Substâncias Luminescentes/farmacologia , Proteínas Recombinantes de Fusão/metabolismo , Equorina/genética , Animais , Apoptose/efeitos dos fármacos , Cádmio/metabolismo , Cálcio/metabolismo , Relação Dose-Resposta a Droga , Substâncias Luminescentes/química , Camundongos , Microscopia de Contraste de Fase , Células NIH 3T3 , Proteínas Recombinantes de Fusão/genética , Espectrofotometria Atômica , Fatores de Tempo
8.
Int J Artif Organs ; 28(10): 1039-50, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16288443

RESUMO

BACKGROUND: Since 1990 our group has been using extracorporeal circulation to ozonate blood by an original method, known as extracorporeal blood oxygenation and ozonation (EBOO), with the aim of amplifying the results observed with ozone autohemotherapy. OBJECTIVE: To verify the hypothesis that EBOO improves the skin lesions typical of peripheral artery disease (PAD) patients. METHODS: Twenty-eight patients with PAD were randomized to receive EBOO or intravenous prostacyclin in a controlled clinical trial. The primary efficacy parameters were regression of skin lesions and pain,and improvement in quality of life and vascularisation. RESULTS: Patients treated with EBOO showed highly significant regression of skin lesions with respect to patients treated with prostacyclin. Other parameters that were significantly different in the two groups of patients were pain,pruritus, heavy legs and well-being. No significant differences in vascularisation of the lower limbs before and after treatment were found in either group. No side effects or complications were recorded during the 210 EBOO treatments. CONCLUSION: EBOO was much more effective than prostacyclin for treating skin lesions in PAD patients and also had a positive effect on patient general condition without any apparent change in arterial circulation. This suggests other mechanisms of action of EBOO.


Assuntos
Arteriopatias Oclusivas/terapia , Epoprostenol/uso terapêutico , Oxigenação por Membrana Extracorpórea/métodos , Ozônio/uso terapêutico , Doenças Vasculares Periféricas/terapia , Úlcera Cutânea/prevenção & controle , Idoso , Idoso de 80 Anos ou mais , Arteriopatias Oclusivas/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Vasculares Periféricas/complicações , Índice de Gravidade de Doença , Úlcera Cutânea/etiologia , Resultado do Tratamento
10.
Prostate Cancer Prostatic Dis ; 18(2): 96-103, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25687401

RESUMO

Permanent radioactive seed implantation provides highly effective treatment for prostate cancer that typically includes multidisciplinary collaboration between urologists and radiation oncologists. Low dose-rate (LDR) prostate brachytherapy offers excellent tumor control rates and has equivalent rates of rectal toxicity when compared with external beam radiotherapy. Owing to its proximity to the anterior rectal wall, a small portion of the rectum is often exposed to high doses of ionizing radiation from this procedure. Although rare, some patients develop transfusion-dependent rectal bleeding, ulcers or fistulas. These complications occasionally require permanent colostomy and thus can significantly impact a patient's quality of life. Aside from proper technique, a promising strategy has emerged that can help avoid these complications. By injecting biodegradable materials behind Denonviller's fascia, brachytherpists can increase the distance between the rectum and the radioactive sources to significantly decrease the rectal dose. This review summarizes the progress in this area and its applicability for use in combination with permanent LDR brachytherapy.


Assuntos
Implantes Absorvíveis , Braquiterapia/efeitos adversos , Neoplasias da Próstata/radioterapia , Humanos , Masculino , Próstata/patologia , Próstata/efeitos da radiação , Neoplasias da Próstata/patologia , Radiação Ionizante , Reto/patologia , Reto/efeitos da radiação , Resultado do Tratamento
11.
Free Radic Biol Med ; 26(3-4): 454-62, 1999 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9895238

RESUMO

A direct correlation has been reported between the severity of symptoms associated with rhinovirus infection and the concentration of interleukin-8 in nasal secretions. The purpose of these studies was to examine the mechanism of rhinovirus-induced IL-8 elaboration. Rhinovirus infection induced oxidative stress in Beas-2b cells and the concentration of H2O2 in supernatant media from rhinovirus challenged cells was 12.5 +/- 6.1 microM 1 h after challenge compared to 0.7 +/- 0.3 microM in supernatant from control cells. N-acetyl cysteine inhibited RV-induced NF-kappaB activation and IL-8 elaboration. IL-8 concentrations were 36 +/- 2 pg/ml and 10 +/- 1 pg/ml 6 h after virus challenge in untreated and NAC-treated (30 mM NAC) cells, respectively. Despite the effects of NAC on IL-8 elaboration and NF-kappaB activation, RV stimulated increases in supernatant H2O2 were not altered by NAC. These data suggest that RV stimulation of IL-8 in respiratory epithelium is mediated through production of oxidative species and the subsequent activation of NF-kappaB.


Assuntos
Células Epiteliais/fisiologia , Interleucina-8/biossíntese , Pulmão/metabolismo , Estresse Oxidativo/fisiologia , Rhinovirus/fisiologia , Acetilcisteína/farmacologia , Linhagem Celular , Células Epiteliais/metabolismo , Humanos , Peróxido de Hidrogênio/farmacologia , Pulmão/citologia , NF-kappa B/metabolismo , Transdução de Sinais/fisiologia , Estimulação Química
12.
Am J Med Genet ; 102(1): 29-35, 2001 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-11471169

RESUMO

We report on a 2-year-old girl with a de novo mutation [45,XX,der(5),t(5;14) (pter;q11.2)] with corpus callosum agenesis, multiple cysts (cerebral and cardiac), subtle eye abnormalities, and at least two different skin defects, strongly indicating neuroectodermal involvement, as a neuromuscular choristoma (hamartoma) and an eccrine hamartoma. Fluorescent in situ hybridization with different single-locus probes showed that chromosome 5 has a very small deletion, confined to a region composed of repetitive sequences. By contrast, the long (q) arm of chromosome 14 seems to be much more involved in the rearrangement, with partial monosomy spanning from the centromere to the D14S72 and D14S261 loci. The extent of the deleted region of chromosome 14 is approximately 16 cM. To our knowledge, this is the smallest reported deletion involving the chromosome 14q11.2 region to be associated with a developmental disorder resulting in variable eye, skin, and brain anomalies. We suggest that a new syndrome, mimicking in some ways the MLS phenotype, is caused by a deletion in the chromosome 14q11.2 region.


Assuntos
Anormalidades Múltiplas/genética , Agenesia do Corpo Caloso , Cistos/patologia , Anormalidades do Olho/patologia , Anormalidades da Pele/patologia , Translocação Genética , Anormalidades Múltiplas/patologia , Bandeamento Cromossômico , Cromossomos Humanos Par 14/genética , Cromossomos Humanos Par 5/genética , Análise Citogenética , Diagnóstico Diferencial , Feminino , Humanos , Hibridização in Situ Fluorescente , Lactente , Cariotipagem , Mutação , Pele/patologia , Pele/ultraestrutura
13.
Hum Pathol ; 31(9): 1018-21, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11014565

RESUMO

Telomerase is an enzyme which synthesizes the telomeres, TTAGGG repeats at the end of vertebrate chromosomes. Its activity is suppressed in the majority of somatic cells, whereas it is detectable in most tumor cell lines and human cancers. Telomerase activity has been evaluated in many tumors for diagnostic purposes, and an increase thereof has been found with tumor progression. In our study we used anonisotopic polymerase chain reaction (PCR)-based TRAP (telomeric repeat amplification protocol) method to quantify the level of telomerase activity in a series of cutaneous melanocytic lesions. Thirty-three benign nevi, 8 dysplastic nevi, 38 malignant melanomas, and 4 melanoma metastases were analyzed. Mean relative telomerase activity was low in benign nevi (3.5+/-2.9), and significantly increased in dysplastic nevi (13.1+/-6.8), malignant melanomas (49.8+/-29.6), and metastases (121.2+/-11.2). In addition to the evaluation of telomerase activity as a possible diagnostic tool, its increase with tumor progression also suggest a prognostic role in cutaneous melanoma.


Assuntos
Melanócitos/enzimologia , Neoplasias Cutâneas/enzimologia , Telomerase/metabolismo , Divisão Celular , Primers do DNA/química , DNA de Neoplasias/análise , Síndrome do Nevo Displásico/enzimologia , Síndrome do Nevo Displásico/patologia , Humanos , Melanócitos/patologia , Melanoma/enzimologia , Melanoma/patologia , Melanoma/secundário , Reação em Cadeia da Polimerase , Pele/enzimologia , Pele/patologia , Neoplasias Cutâneas/patologia
14.
Arch Dermatol ; 135(12): 1459-65, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-10606050

RESUMO

OBJECTIVES: To use a digital dermoscopy analyzer with a series of "borderline" pigmentary skin lesions (ie, clinically atypical nevi and early melanoma) to find correlation between the studied variables and to determine their discriminating power with respect to histological diagnosis. DESIGN: A total of 147 pigmentary skin lesions were histologically examined by 3 experienced dermatopathologists and identified as nevi (n = 90) and melanomas (n = 57). The system evaluated 36 variables to be studied as possible discriminant variables, grouped into 4 categories: geometries, colors, textures, and islands of color. SETTING: University medical department. PATIENTS: A sample of patients with excised pigmentary skin lesions (nevi and melanomas). MAIN OUTCOME MEASURES: Sensitivity, specificity, and accuracy of the model for evaluating "borderline" pigmentary skin lesions. RESULTS: After multivariate stepwise discriminant analysis, only 13 variables were selected to compute the canonical discriminant function. CONCLUSION: The present method made it possible to determine which objective variables are important for distinguishing atypical benign pigmentary skin lesions and early melanoma.


Assuntos
Endoscópios , Processamento de Imagem Assistida por Computador/instrumentação , Melanoma/diagnóstico , Nevo Pigmentado/diagnóstico , Neoplasias Cutâneas/diagnóstico , Adulto , Idoso , Diagnóstico Diferencial , Feminino , Humanos , Aumento da Imagem/instrumentação , Masculino , Melanoma/patologia , Pessoa de Meia-Idade , Nevo Pigmentado/patologia , Sensibilidade e Especificidade , Pele/patologia , Neoplasias Cutâneas/patologia
15.
Melanoma Res ; 11(1): 37-44, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11254114

RESUMO

Epiluminescence light microscopy (ELM) has proven useful in the diagnosis of pigmented skin lesions (PSLs). However, in some cases this technique does not sufficiently increase the diagnostic accuracy in distinguishing pigmented Spitz naevi (PSNs) from melanoma. With the aim of obviating these problems of qualitative interpretation, methods based on the mathematical analysis of PSLs, such as digital dermoscopy analysis (DDA), have recently been developed. In the present study we used a digital dermoscope (DBDermo-MIPS, Dell'Eva-Burroni) to analyse PSNs and melanomas with similar clinical and dermoscopic features for any correlation between variables and to determine its discriminating power with respect to histological diagnosis. The 100 lesions underwent histological examination by three experienced dermatopathologists and were identified as PSNs (43) or melanomas (57). Thirty-six parameters were identified as possible discriminating variables and were grouped in four categories: geometry, colour, texture, and islands of colour. Statistical analysis was used to identify the variables with the highest discriminating power. Stepwise discriminant analysis selected only four variables: entropy, minimum diameter, red lesion value and peripheral dark (the means of these variables were higher in melanomas than in PSNs). Thus the combined use of digital dermoscopy and stepwise logistic discriminant analysis made it possible to single out the best objective variables for distinguishing PSN and melanoma.


Assuntos
Dermatologia/métodos , Melanoma/diagnóstico , Melanoma/patologia , Microscopia/métodos , Nevo de Células Epitelioides e Fusiformes/diagnóstico , Neoplasias Cutâneas/diagnóstico , Dermatologia/instrumentação , Humanos , Modelos Logísticos , Microscopia/instrumentação , Modelos Teóricos , Curva ROC , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Neoplasias Cutâneas/patologia , Software
16.
Arch Dermatol Res ; 285(5): 250-4, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8397492

RESUMO

Squamous papillae of the vulvar vestibule and introitus are quite a common clinical finding, however their origin is uncertain. They were formerly described as a normal variant of the mucosal epithelium, but recently they have been attributed to human papillomavirus (HPV) infection. Eight women with clinical findings compatible with a diagnosis of vulvar squamous papillomatosis were studied. All were free of other clinically evident HPV-related diseases. Vulvar scrapes and biopsy specimens were collected and used for DNA extraction and microscopic examination. DNA extracted from vulvar scrapings and from paraffin-embedded tissue was subjected to polymerase chain reaction (PCR). The reactions were performed with two sets of primers designed for the amplification of numerous HPV genotypes including those most commonly encountered in the genital area. Histological examination failed to reveal clear-cut signs of HPV infection in any subject. The PCR on the DNA extracted from vulvar scrapings revealed HPV infection in two cases. PCR performed on the DNA extracted from the paraffin-embedded tissue failed to detect HPV-DNA in any case. A 6-month follow-up showed no changes in the lesions. These results along with literature data, which is clearly inconsistent, indicated that the presence of HPV is coincident to, rather than causal of, vulvar squamous papillomatosis lesions. Patients with symmetrically distributed, long-standing vulvar papillae should, therefore, be carefully evaluated before starting therapy.


Assuntos
DNA Viral/análise , Papiloma/microbiologia , Papillomaviridae/isolamento & purificação , Reação em Cadeia da Polimerase , Infecções Tumorais por Vírus/complicações , Neoplasias Vulvares/microbiologia , Adulto , Sequência de Bases , Feminino , Humanos , Dados de Sequência Molecular , Papiloma/complicações , Papiloma/patologia , Papillomaviridae/genética , Vulva/patologia , Neoplasias Vulvares/complicações , Neoplasias Vulvares/patologia
17.
Arch Dermatol Res ; 273(1-2): 9-14, 1982.
Artigo em Inglês | MEDLINE | ID: mdl-6191724

RESUMO

The effect of some agents, influencing the cyclic adenosine 3', 5'-monophosphate (cAMP) content of human cells, on the ability of the keratinocytes of binding pemphigus antibodies was studied by using tissue cultures of rabbit esophagus. As demonstrated by immunofluorescence (IF) for IgG, the bound antibodies appeared markedly decreased on esophagus explants grown under standard conditions, that is without test agents, when compared to ones fixed on fresh esophagus. But the IF reaction was remarkably more intense when methylxanthines or epinephrine were added to the growth medium of the cultures. Following the addition of these agents to the cultures some histologic modifications appeared in the explants, indicating that the keratinization process had probably been stimulated. This temporal relationship of immunofluorescence and histologic findings seems to suggest the hypothesis that keratinocyte differentiation, regulation of cAMP intracellular content, and pemphigus antibodies fixation are related processes.


Assuntos
Afinidade de Anticorpos , AMP Cíclico/metabolismo , Células Epidérmicas , Pênfigo/imunologia , 1-Metil-3-Isobutilxantina/farmacologia , Animais , Diferenciação Celular , Epinefrina/farmacologia , Esôfago/citologia , Humanos , Técnicas de Cultura de Órgãos , Propranolol/farmacologia , Coelhos , Teofilina/farmacologia
18.
Talanta ; 47(2): 343-8, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18967334

RESUMO

The complex formation between Cu(II) and dl-willardiine [1-(2-amino-2-carboxyethyl)uracil], an analog of phenylalanine containing the uracil residue, was investigated by potentiometric and spectral studies. The results indicate that the primary metal binding site of the ligand is the alpha-amino-carboxylate chelating set. The uracil moiety, however, can coordinate the metal ion in basic solution giving rise to intermolecular bridging.

19.
J Dermatolog Treat ; 12(1): 25-8, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12171684

RESUMO

We report the case of a road accident victim who sustained fracture of the frontal bone and extensive skin loss. Immediate repair of the skin breach was necessary to protect the set bone fragments. Intraoperative skin expansion provided an immediate gain in tissue and avoided the waiting period required with traditional expansion methods. Besides an excellent immediate functional result, acceptable aesthetic results, confirmed 6 months later, were also obtained.


Assuntos
Couro Cabeludo/cirurgia , Fraturas Cranianas/cirurgia , Expansão de Tecido/métodos , Acidentes de Trânsito , Humanos , Cuidados Intraoperatórios , Couro Cabeludo/lesões , Fraturas Cranianas/etiologia , Retalhos Cirúrgicos , Dispositivos para Expansão de Tecidos
20.
J Submicrosc Cytol Pathol ; 24(3): 315-21, 1992 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1394087

RESUMO

The differential diagnosis between keratoacanthoma (KA) and well differentiated squamous cell carcinoma (WDSCC) is not always easy to perform. Seven cases of KA and seven cases of WDSCC have been here analyzed by morphometry on ultrastructural sections and compared with normal epidermis. Parameters expressing the cohesivity among epithelial cells (numerical and surface density of desmosomes; volume density of intercellular space) were significantly different in KA and WDSCC, so that they may be useful in differential diagnosis. The Authors also questioned the nature of KA, suggesting a continuum between this lesion and WDSCC.


Assuntos
Carcinoma de Células Escamosas/patologia , Ceratoacantoma/patologia , Neoplasias Cutâneas/patologia , Carcinoma de Células Escamosas/ultraestrutura , Desmossomos/ultraestrutura , Diagnóstico Diferencial , Espaço Extracelular , Humanos , Neoplasias Cutâneas/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA